Key result
Age ≥75 linked to ~147% higher 90-day mortality vs age <60 after infective endocarditis surgery.
Why the study?
The balance between benefit and harm of surgery for infective endocarditis is difficult and may be closely related to age and surgical intervention type.
Does older age and complex left-sided valvular surgery increase mortality in patients undergoing surgery for infective endocarditis?
Cohort (n=1,767)
Yes
Does older age and complex left-sided valvular surgery increase mortality in patients undergoing surgery for infective endocarditis?
In patients undergoing surgery for infective endocarditis, mortality increases significantly with age and complexity of valve surgery, with 1 in 5 patients over 75 dying within 90 days.
Advanced age may heighten 90-day mortality risk after endocarditis surgery; prospective studies needed to guide age-specific thresholds.
BACKGROUND: Infective endocarditis (IE) is associated with high mortality. Surgery may improve survival and reduce complications, but the balance between benefit and harm is difficult and may be closely related to age and type of surgical intervention. We aimed to examine how age and type of left-sided surgical intervention modified mortality in patients undergoing surgery for IE. METHODS: By crosslinking nationwide Danish registries we identified patients with first-time IE undergoing surgical treatment 2000-2017. Patients were grouped by age < 60 years, 60-75 years, and ≥ 75 years. Multivariable adjusted Cox proportional hazard analysis was used to examine factors associated with 90-day mortality. RESULTS: We included 1767 patients with IE undergoing surgery, 735 patients < 60 years (24.1% female), 766 patients 60-75 years (25.8% female), and 266 patients ≥75 years (36.1% female). The proportions of patients undergoing surgery were 35.3, 26.9, and 9.1% for patients < 60 years, 60-75 years, and > 75 years, respectively. Mortality at 90 days were 7.5, 13.9, and 22.3% (p < 0.001) for three age groups. In adjusted analyses, patients 60-75 years and patients ≥75 years were associated with a higher mortality, HR = 1.84 (95% CI: 1.48-2.29) and HR = 2.47 (95% CI: 1.88-3.24) as compared with patients < 60 years. Factors associated with 90-day mortality were: mitral valve surgery, a combination of mitral and aortic valve surgery as compared with isolated aortic valve surgery, age, diabetes, and prosthetic heart valve implantation prior to IE admission. CONCLUSIONS: In patients undergoing surgery for IE, mortality increased significantly with age and 1 in 5 died above age 75 years. Mitral valve surgery as well as multiple valve interventions augmented mortality further.
No takes yet. Share an insight, caveat, or question.
Østergaard et al. (2020) conducted a cohort in Infective endocarditis (IE) undergoing surgical treatment (n=1,767). Age ≥75 years vs. Age <60 years was evaluated on 90-day all-cause mortality (HR 2.47, 95% CI 1.88-3.24, p=<0.001). In patients undergoing surgery for infective endocarditis, age ≥75 years was associated with a significantly higher 90-day mortality compared to age <60 years (HR 2.47).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: